NCT07060144

Brief Summary

Pregnant women with a primary diagnosis of posttraumatic stress disorder (PTSD) (PTSD Checklist for DSM-5 (PCL-5) score \> 33) will be randomized to receive conventional cognitive processing therapy (CPT) (60-min session once/week for 12 weeks) or massed CPT (mCPT) (an intensive schedule of 12 60-min sessions over 5 days, approximately 2-3 sessions per day) via telemedicine, for treatment of PTSD. The research aims will be three-fold: (1) Evaluate the relative efficacy and tolerability of CPT vs. mCPT for treatment of perinatal PTSD and depression; (2) Determine the effect of CPT upon maternal-infant attachment and interaction; (3) Collect pilot data of obstetric and neonatal outcomes among those receiving the two CPT delivery schedules.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress60%
Jul 2025Dec 2026

First Submitted

Initial submission to the registry

June 24, 2025

Completed
7 days until next milestone

Study Start

First participant enrolled

July 1, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 11, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

July 11, 2025

Status Verified

July 1, 2025

Enrollment Period

1.4 years

First QC Date

June 24, 2025

Last Update Submit

July 8, 2025

Conditions

Keywords

PTSDpregnancycognitive processing therapypsychotherapytrauma

Outcome Measures

Primary Outcomes (1)

  • Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5)

    PTSD Checklist for DSM-5 (PCL-5) will be used to collect information on PTSD symptoms. The PCL-5 for DSM-5 is a 20-item self-report measure. Higher scores reflect greater PTSD severity. Scoring is based on how much the patient has been bothered by the symptoms on a scale from "0 = not at all" to "4 = extremely." PCL-5 total symptom severity scores range from 0 to 80 with higher scores indicating greater PTSD severity. PCL-5 Monthly will be collected at Visit 1, and the PCL-5 weekly will be collected at 1 week, 4 weeks, 8 weeks, 12 weeks, and 16 weeks following initiation of treatment in both groups.

    Baseline, then at 1 week, 4 weeks, 8 weeks, 12 weeks, and 16 weeks following initiation of treatment in both the mCPT and traditional CPT groups

Secondary Outcomes (4)

  • Patient Health Questionnaire (PHQ-9)

    Baseline, then at 1 week, 4 weeks, 8 weeks, 12 weeks, and 16 weeks following initiation of treatment in both the mCPT and traditional CPT groups

  • Prenatal Attachment Inventory (PAI)

    Baseline

  • Maternal Attachment Inventory (MAI)

    Once within 1-90 days following participant's delivery (i.e once within 3 months postpartum)

  • Infant CARE-Index (CARE-Index)

    Once within 1-90 days following participant's delivery (i.e once within 3 months postpartum)

Study Arms (2)

Regular CPT

EXPERIMENTAL

Standard-model Cognitive Processing Therapy (CPT) - one 60-min session per week for 12 weeks total

Behavioral: Regular CPT

mCPT

EXPERIMENTAL

Massed CPT - two 60-min sessions each day for 5 consecutive days (10 sessions total)

Behavioral: Massed CPT

Interventions

Regular CPTBEHAVIORAL

Standard-model Cognitive Processing Therapy (CPT) - one 60-min session per week for 12 weeks total

Regular CPT
Massed CPTBEHAVIORAL

Massed CPT - two 60-min sessions each day for 5 consecutive days (10 sessions total)

mCPT

Eligibility Criteria

Age18 Years - 46 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Female, ages 18-46, Pregnant (\< 25 weeks), able to read and write in English, History of at least 1 criterion A trauma, Primary diagnosis of PTSD (confirmed by SCID), Psychotropic medications must be stable with no changes ≥ 2 weeks (≥ 6 weeks for fluoxetine), and no medication changes can be made during the course of therapy

You may not qualify if:

  • Not currently pregnant, Diagnosis of bipolar disorder, psychotic disorders, Suicidal ideation with plan or intent, Substance use disorder, Regular benzodiazepine use (\> 4x weekly)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas at Austin, Dell Medical School, Department of Psychiatry

Austin, Texas, 78701, United States

RECRUITING

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticWounds and Injuries

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Erin Richardson

    University of Texas at Austin

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Advanced Practice Nurse

Study Record Dates

First Submitted

June 24, 2025

First Posted

July 11, 2025

Study Start

July 1, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

July 11, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations